Clinical trials
Emphysema trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 11 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Medical Center Groningen | 10 |
| Boston Scientific Corporation | 6 |
| Pulmonx Corporation | 5 |
| Aeris Therapeutics | 2 |
| Apreo Health, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Pulmair Medical, Inc. | 2 |
| AIRNA Corporation | 1 |
| AstraZeneca | 1 |
| Broncus Technologies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 39 |
| Pulmonary Disease, Chronic Obstructive | 26 |
| Pulmonary Emphysema | 5 |
| Lung Diseases | 4 |
| Respiratory Tract Diseases | 4 |
| alpha 1-Antitrypsin Deficiency | 4 |
| Bronchitis, Chronic | 3 |
| Genetic Diseases, Inborn | 2 |
| Lung Diseases, Obstructive | 2 |
| Pathologic Processes | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.